These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19152810)

  • 1. Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses.
    Oh S; Selleck P; Temperton NJ; Chan PK; Capecchi B; Manavis J; Higgins G; Burrell CJ; Kok T
    J Virol Methods; 2009 May; 157(2):161-7. PubMed ID: 19152810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
    Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
    Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.
    Oh HL; Akerström S; Shen S; Bereczky S; Karlberg H; Klingström J; Lal SK; Mirazimi A; Tan YJ
    J Virol; 2010 Aug; 84(16):8275-86. PubMed ID: 20519402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibodies to highly pathogenic avian influenza A(H5N1) strain isolated in the Russian Federation: development and properties].
    Kushch AA; Klimova RR; Masalova OV; Fedorova NE; Botikov AG; Fediakina IT; Burtseva EI; Isaeva EI; Deriabin PG; L'vov DK
    Vopr Virusol; 2008; 53(5):9-14. PubMed ID: 19069786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of monoclonal antibodies reactive against subtype specific conserved B-cell epitopes on haemagglutinin protein of influenza virus H5N1.
    Fiebig P; Shehata AA; Liebert UG
    Virus Res; 2015 Mar; 199():46-55. PubMed ID: 25599601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
    Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
    Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
    Gronsang D; Bui AN; Trinh DQ; Bui VN; Nguyen KV; Can MX; Omatsu T; Mizutani T; Nagai M; Katayama Y; Thampaisarn R; Ogawa H; Imai K
    Arch Virol; 2017 Aug; 162(8):2257-2269. PubMed ID: 28405766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
    Cabral TM; Berhane Y; Schmidt L; Tracz DM; Hole K; Leith M; Corbett CR
    J Virol Methods; 2012 Jul; 183(1):25-33. PubMed ID: 22575685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterisation of monoclonal antibodies against influenza virus A, subtype H5N1.
    Linke S; Neubauer K; Dorner MB; Dorner BG; Pauli G; Schweiger B
    J Virol Methods; 2011 Jul; 175(1):85-94. PubMed ID: 21549148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies.
    Ho HT; Qian HL; He F; Meng T; Szyporta M; Prabhu N; Prabakaran M; Chan KP; Kwang J
    Clin Vaccine Immunol; 2009 May; 16(5):726-32. PubMed ID: 19321691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.
    Tsai C; Caillet C; Hu H; Zhou F; Ding H; Zhang G; Zhou B; Wang S; Lu S; Buchy P; Deubel V; Vogel FR; Zhou P
    Vaccine; 2009 Nov; 27(48):6777-90. PubMed ID: 19732860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
    Lim AP; Chan CE; Wong SK; Chan AH; Ooi EE; Hanson BJ
    Virol J; 2008 Oct; 5():130. PubMed ID: 18957074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies.
    Du L; Zhao G; Zhang X; Liu Z; Yu H; Zheng BJ; Zhou Y; Jiang S
    Biochem Biophys Res Commun; 2010 Jul; 397(3):580-5. PubMed ID: 20617558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody.
    Du A; Daidoji T; Koma T; Ibrahim MS; Nakamura S; de Silva UC; Ueda M; Yang CS; Yasunaga T; Ikuta K; Nakaya T
    Biochem Biophys Res Commun; 2009 Jan; 378(2):197-202. PubMed ID: 19010309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and characterization of monoclonal antibodies against M2 protein of avian influenza virus].
    Li YQ; Yang J; Zhang L; Wei L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):475-8. PubMed ID: 18466706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.